Jefferies raises Tango Therapeutics stock price target on trial data
AI Summary
Jefferies raised its price target for Tango Therapeutics following trial data. The article description does not specify the data or the revised target.
Related Articles
Tinubu seeks Reps approval to implement N10.79tn external borrowing plan
Punch Nigeria —
Nigeria woos investors for CNG, EV expansion
Punch Nigeria —
Wizz Air to Move Budapest Flights to Brussels’ Main Airport in February
Budapest Business Journal —
Russian foreign trade surplus down to $12.1 bln in September 2026 — Central Bank
TASS —
Cost of Russian gas, rising demand, situation in Europe: what we know
TASS —
Earnings call transcript: ITG posts strong Q3 2026 growth, stock barely moves
Investing.com —